- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02188004
The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
May 5, 2019 updated by: Jun Zhang
The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases In Male and Female Aged Over 18 Years In China
primary purpose:Evaluate the prevalence and incidence of HPV infection and related diseases in subjects.
Secondary purpose:Analyze risk factors of HPV infection and related diseases.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
4691
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangxi
-
Liuzhou, Guangxi, China
- Liuzhou Center of disease prevention and control
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
5000 healthy volunteers will be recruited from the residents of Liuzhou through advertisment.
Description
Inclusion Criteria:
- ages 18 to 55 years;
- residents of the study site;
- at least one sex partner;
- Be able to understand and comply with the request of the protocol.
Exclusion Criteria:
- pregnant;
- has received HPV vaccines.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
prevalence and incidence of HPV infection
Time Frame: 1 year
|
Evaluate the prevalence and incidence of HPV infection and related diseases in subjects
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
risk factors of HPV infection and related diseases
Time Frame: 1 year
|
Analyze risk factors of HPV infection and related diseases.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Jun Zhang, Xiamen University
- Principal Investigator: Ming-Qiang Li, Liuzhou Center of disease prevention and control
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2014
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
May 1, 2016
Study Registration Dates
First Submitted
July 9, 2014
First Submitted That Met QC Criteria
July 9, 2014
First Posted (Estimate)
July 11, 2014
Study Record Updates
Last Update Posted (Actual)
May 7, 2019
Last Update Submitted That Met QC Criteria
May 5, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Skin Diseases
- Virus Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Disease Attributes
- DNA Virus Infections
- Skin Diseases, Infectious
- Warts
- Skin Diseases, Viral
- Tumor Virus Infections
- Infections
- Communicable Diseases
- Papillomavirus Infections
- Condylomata Acuminata
Other Study ID Numbers
- HPV-EPI-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Human Papillomavirus Infection
-
The AlfredMerck Sharp & Dohme LLCCompletedHuman Papillomavirus Infection | Human PapillomavirusAustralia
-
Centre Hospitalier Universitaire de BesanconCompletedHuman Papillomavirus InfectionFrance
-
University Hospital, GenevaCompletedHuman Papillomavirus InfectionSwitzerland
-
University of ConnecticutCompletedHuman Papillomavirus Infection
-
Indiana UniversityMerck Sharp & Dohme LLCUnknownHuman Papillomavirus InfectionUnited States
-
Gen-Probe, IncorporatedCompletedHuman Papillomavirus InfectionUnited States
-
GlaxoSmithKlineCompletedHuman Papillomavirus Infection
-
GlaxoSmithKlineCompletedHuman Papillomavirus InfectionEgypt
-
University Hospital, GenevaUnknown
-
Gen-Probe, IncorporatedCompletedHuman Papillomavirus InfectionUnited States